Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage biopharmaceutical company ...
Giant omphalocoeles, defined by a defect larger than 5 cm or significant liver herniation, present unique challenges due to viscero-abdominal disproportion. Traditional staged closure techniques aim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback